Baltimore, Maryland 21287

  • Hyperglycemia Due to Type 2 Diabetes Mellitus

Purpose:

The purpose of this prospective study is to determine if trial use of a Dexcom G6 CGM system for a 10 day wear period in pediatric Type 2 diabetes patients improves short term time in range glucose control and 3-6 month glycemic control.


Criteria:

Inclusion Criteria: - Type 2 diabetes, diabetes duration >3 months Exclusion Criteria: - Prior use of CGM


NCT ID:

NCT04721158


Primary Contact:

Principal Investigator
Risa M Wolf, MD
Johns Hopkins School of Medicine

Risa M Wolf, MD
Phone: 410955-6463
Email: rwolf@jhu.edu


Backup Contact:

Email: smagge3@jhmi.edu
Sheela N Magge, MD, MSCE
Phone: 410-955-6463


Location Contact:

Baltimore, Maryland 21287
United States

Risa M Wolf, MD
Phone: 410-955-6463
Email: rwolf@jhu.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: June 24, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.